Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-23-073906
Filing Date
2023-12-29
Accepted
2023-12-29 17:04:20
Documents
1
Period of Report
2023-12-29

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1477
  Complete submission text file 0000950170-23-073906.txt   2994
Mailing Address 200 CLARENDON STREET C/O BAIN CAPITAL LIFE SCIENCES, LP BOSTON MA 02116
Business Address
Downing Nicholas (Reporting) CIK: 0001876110 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41562 | Film No.: 231528446

Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Issuer) CIK: 0001936258 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)